Evidence map›Paper›PMID 38379394›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Biomarkers associated with cardiovascular disease in women with spontaneous preterm birth: A case-control study.

Elin Täufer Cederlöf, Susanne Lager, Anders Larsson, Inger Sundström Poromaa, Bertil Lindahl, Anna-Karin Wikström, Christina Christersson

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05693285 (Preterm Birth and Biomarkers for Cardiovascular Disease), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05693285 completednot on this map

Preterm Birth and Biomarkers for Cardiovascular Disease

TypeobservationalSponsorUppsala UniversityRan2022 to 2022Enrolled65ConditionsPreterm Birth, Cardiovascular DiseasesArmsNo intervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Elin Täufer CederlöfDepartment of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
Susanne LagerDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-3556-065X
Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Inger Sundström PoromaaDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Bertil LindahlDepartment of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.
Anna-Karin WikströmDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Christina ChristerssonDepartment of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-9116-8084
Uppsala University · SE

Funding

King Gustaf V's and Queen Victoria's Masonic Foundation
6 · The paper itself

Abstract

introductionWomen with spontaneous preterm birth have an increased risk of cardiovascular disease later in life. Studies suggest potential pathophysiological mechanisms in common, but whether these could be identified by measurement of soluble circulating protein biomarkers in women with spontaneous preterm birth is unknown. The aim of this study was to determine if protein biomarkers associated with cardiovascular disease distinguish women with spontaneous preterm birth from healthy controls, both at pregnancy and at follow up. MATERIAL AND

methodsStudy participants were identified in the population-based Uppsala biobank of pregnant women in Sweden, where plasma samples were collected in mid-pregnancy. In a first screening phase, we identified participants who subsequently experienced spontaneous preterm birth (<37 weeks) in the index pregnancy (N = 13) and controls (N = 6). In these samples, differences in protein expression were examined by comparative mass spectrometry. In a second validation phase, we invited 100 cases with previous spontaneous preterm birth in the index pregnancy and 100 controls (matched for age, body mass index, and year of delivery) from the same source population, to a follow-up visit 4-15 years after pregnancy. At follow up, we collected plasma samples and data on cardiovascular risk factors. We measured concentrations of selected biomarkers identified in the screening phase, as well as lipid profiles in samples both from pregnancy (biobank) and follow up. CLINICALTRIALS: gov registration NCT05693285.

resultsIn the screening phase, fibrinogen, cadherin-5, complement C5, factor XII, plasma kallikrein, apolipoprotein M, and vitamin D-binding protein differed significantly at pregnancy. In the validation phase, 65 women agreed to participate (35 cases and 30 controls), with a median follow-up time of 11.8 years since pregnancy. The concentration of fibrinogen (p = 0.02) and triglycerides (p = 0.03) were slightly higher in cases compared with matched controls at follow up.

conclusionsCompared with women without preterm birth, those with spontaneous preterm birth had slightly higher concentrations of fibrinogen, both at mid-pregnancy and a decade after pregnancy. Additionally, we found slightly higher concentration of triglycerides at follow up in women with previous spontaneous preterm birth. The relevance of this finding is uncertain but might indicate potential pathophysiological mechanisms in common between spontaneous preterm birth and cardiovascular disease.

Indexed as

Cardiovascular DiseasesPremature BirthBiomarkersCase-Control StudiesFemaleFibrinogenHumansInfant, NewbornPregnancyTriglyceridesBiomarkersFibrinogenTriglyceridescardiovascular diseasefibrinogenmolecular biologypregnancypreterm birthprotein biomarkerstriglycerides

Identifiers

PMID38379394
PMCPMC11019525
OpenAlexW4392000556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.